In a new study, researchers will examine if changing our mealtimes to earlier or later in the day could reduce the risk of developing Type 2 diabetes.
Anna Forsberg, Professor of Transplant Nursing at Lund University and Chair of the ETAHP Committee at the ESOT, explores a key area of development in heart transplant nursing as part of the build-up to ESOT Congress 2021.
The new UK Rare Diseases Framework sets out to accelerate diagnosis and improve the treatment of rare diseases.
Justin Hall, GM and VP EMEA, iRhythm Technologies, explores how modern technology is helping to diagnose Atrial Fibrillation (AF).
Here, Mary Wilson, Paralympic athlete, shares her personal experience and health journey to highlight the importance of supporting disabled female athletes.
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces ImotopesTM a cutting-edge immunotherapy science with an excellent safety profile that could cure Type 1 diabetes or drastically change treatment options.
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, shares her expertise on the transmission of Diarrheagenic E. coli by plants.
Claus Møldrup, DrugsDisclosed.com Founder and Former Professor in Social Pharmacy at the University of Copenhagen, turns the spotlight on diabetes and explores how to improve patient wellbeing and national health outcomes.
Open Access Government was privileged to speak with Dr Mary Stephen again, Public Health Expert at the World Health Organization African Region, about suppressing the spread of COVID-19, remaining vigilant and effectively tackling any resurgence.
Gary Lacasse, Executive Director with Kelly Puddister and Patrick Wright from the Canadian AIDS Society, argue that Canada is far behind other G7 countries in eliminating new HIV infections, with a 25.3% increase in new cases reported between 2014 and 2018.
Prof Monica Di Luca, President, European Brain Council, sheds light on brain conditions, mental and neurological alike, starting with comment on the burdens presented.
Dr Katie Howe, Research Communications Manager at the MS Society charts a vision of a world free from the effects of multiple sclerosis.
Samantha Benham-Hermetz, Director of Policy and Public Affairs at Alzheimer’s Research UK charts us through the priorities for dementia research in the UK in light of COVID-19.
Here the InBody Clinical Team explain how improved body composition can help fight type 2 diabetes.
Daniel Berman from Nesta Challenges and Colin Capper at the Alzheimer’s Society focus here on dementia tech, including comment on overcoming barriers to innovation post-pandemic.
Dementia UK’s Head of Research and Publications, Dr Karen Harrison Dening, discusses her thoughts on the diagnosis of dementia and the impact of COVID-19 on this.
Over 12 US Immigration and Customs Enforcement (ICE) detention centres had multiple outbreaks of infectious disease - due to withholding vaccines for adult and child migrants.
New research by the University of East Anglia found that 70% of people with dementia go missing - but why?
According to a new analysis, COVID-19 patients have shown lasting skin problems long after their initial infection has cleared.
Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences, explain why a herd immunity approach to COVID-19 would include great risk, potentially many deaths, and may simply not work.